By vgreene, 5 January, 2017 If on PO combination, move to basal insulin (usually w/ metformin +/- other noninsulin agent)
By vgreene, 5 January, 2017 If A1C target1 not achieved after 3mo of dual tx, consider med-taking behavior, consider triple tx
By vgreene, 5 January, 2017 If pt not achieving glycemic goals, do not delay drug intensification, incl insulin tx [B]
By vgreene, 5 January, 2017 If no ASCVD and dual tx at max-tolerated dose doesn't achieve A1C target after 3mo, add additional oral agent based on drug-specific2 and pt factors [A]
By vgreene, 5 January, 2017 Drug- and pt-specific factors to consider when selecting antihyperglycemic tx
By vgreene, 5 January, 2017 Drug- and pt-specific factors to consider when selecting antihyperglycemic tx Table 1
